Common use of Consolidated Adjusted EBITDA Clause in Contracts

Consolidated Adjusted EBITDA. Company shall not permit Consolidated Adjusted EBITDA as at the end of any Fiscal Quarter, beginning with the Fiscal Quarter ending September 30, 2020, for the four Fiscal Quarter period then ended to be less than the correlative amount indicated below (with corresponding calendar quarters also included as reference): Fiscal Quarter Ending Consolidated Adjusted EBITDA (in thousands) September 30, 2020 ($11,179) December 31, 2020 ($10,858) March 31, 2021 ($10,970) 72 Fiscal Quarter Ending Consolidated Adjusted EBITDA (in thousands) June 30, 2021 ($10,888) September 30, 2021 ($11,401) December 31, 2021 ($11,038)

Consolidated Adjusted EBITDA. Company shall not permit Consolidated Adjusted EBITDA as at the end of any Fiscal Quarter, beginning with Quarter (i) from the Fiscal Quarter ending Closing Date until September 30, 20202024, for the period of the Fiscal Quarters then ended in such calendar year and (ii) from October 1, 2024, for the four Fiscal Quarter period then ended ended, to be less than the correlative amount indicated below (with corresponding calendar quarters also included as reference): Fiscal Quarter Ending Consolidated EndingConsolidated Adjusted EBITDA (in thousands) March 31, 2024 $1,000,000 June 30, 2024 $1,500,000 September 30, 2020 (2024 $11,179) 2,500,000 December 31, 2020 (2024 $10,858) 4,000,000 March 31, 2021 (2025 $10,970) 72 Fiscal Quarter Ending Consolidated Adjusted EBITDA (in thousands) 5,000,000 June 30, 2021 (2025 $10,888) 5,500,000 September 30, 2021 (2025 $11,401) 6,000,000 December 31, 2021 (2025 $11,038)6,500,000 March 31, 2026 $8,000,000 June 30, 2026 $8,000,000 September 30, 2026 $8,000,000 ​

Consolidated Adjusted EBITDA. Company shall not permit Consolidated Adjusted EBITDA as at the end of any Fiscal Quarter, beginning with the Fiscal Quarter ending September 30, 20202019, for the four Fiscal Quarter period then ended to be less than the correlative amount indicated below (with corresponding calendar quarters also included as reference): below: Fiscal Quarter Ending Consolidated Adjusted EBITDA (in thousands) September 30, 2019 -$17,250,000 December 31, 2019 -$24,000,000 March 31, 2020 -$28,500,000 June 30, 2020 -$23,750,000 September 30, 2020 ($11,179) -$16,500,000 December 31, 2020 ($10,858) -$7,750,000 March 31, 2021 ($10,970) 72 Fiscal Quarter Ending Consolidated Adjusted EBITDA (in thousands) 0 June 30, 2021 ($10,888) 0 September 30, 2021 ($11,401) -$10,000,000 December 31, 2021 (-$22,000,000 March 31, 2022 N/A June 30, 2022 N/A September 30, 2022 N/A December 31, 2022 -$13,000,000 March 31, 2023 -$5,000,000 June 30, 2023 $11,038)2,000,000 September 30, 2023 $10,000,000 December 31, 2023 $18,500,000 March 31, 2024 $20,000,000 June 30, 2024 $20,000,000 September 30, 2024 $20,000,000

Consolidated Adjusted EBITDA. Company shall not permit Consolidated Adjusted EBITDA as at the end of any Fiscal Quarter, beginning with the Fiscal Quarter ending September 30, 2020, for the four Fiscal Quarter period then ended to be less than the correlative amount indicated below (with corresponding calendar quarters also included as reference): Fiscal Quarter Ending Consolidated EndingConsolidated Adjusted EBITDA (in thousands) September 30, 2020 ($11,179) December 31, 2020 ($10,858) March 31, 2021 ($10,970) 72 Fiscal Quarter Ending Consolidated Adjusted EBITDA (in thousands) June 30, 2021 ($10,888) September 30, 2021 ($11,401) December 31, 2021 ($11,038)) March 31, 2022 ($11,347) June 30, 2022 ($10,788) September 30, 2022 ($10,573) December 31, 2022 ($10,527) March 31, 2023 ($10,694) June 30, 2023 ($10,274) ​

Consolidated Adjusted EBITDA. Company Holdings shall not permit Consolidated Adjusted EBITDA as at the end of any Fiscal Quarter, beginning with the Fiscal Quarter ending September 30March 31, 20202017, for the four Fiscal Quarter period then ended to be less than the correlative amount indicated below (with corresponding calendar quarters also included as reference): indicated: Fiscal Quarter Ending Consolidated Adjusted EBITDA (in thousands) March 31, 2017 $ 13,250,000 June 30, 2017 $ 13,250,000 September 30, 2017 $ 13,250,000 December 31, 2017 $ 13,250,000 March 31, 2018 $ 13,500,000 June 30, 2018 $ 13,500,000 September 30, 2018 $ 14,000,000 December 31, 2018 $ 14,000,000 March 31, 2019 $ 14,500,000 June 30, 2019 $ 14,500,000 September 30, 2019 $ 15,000,000 December 31, 2019 $ 15,000,000 March 31, 2020 $ 15,000,000 June 30, 2020 $ 15,000,000 September 30, 2020 ($11,179) December 31, 2020 ($10,858) March 31, 2021 ($10,970) 72 and each Fiscal Quarter Ending Consolidated Adjusted EBITDA (in thousands) June 30, 2021 ($10,888) September 30, 2021 ($11,401) December 31, 2021 ($11,038)ending thereafter $ 15,000,000